Where Does IDegLira Fit in the Type 2 Diabetes Treatment Armamentarium?
John Buse, MD, PhD, of the UNC School of Medicine, discusses the "interesting properties" of insulin degludec/liraglutide (IDegLira) for treatment of type 2 diabetes. He compares the combination drug with its individual components, noting that IDegLira offers some benefits that insulin and liraglutide do not on their own.
Additionally, Dr Buse offers insight into where IDegLira will fit into the type 2 diabetes treatment landscape. Although clinicians will undoubtedly spend the next few years learning more, he said, it will likely be very beneficial for certain patients who experience difficulty in achieving glycemic control.